• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在C3缺陷患者血清中发现的一种血清因子对免疫性溶血的抑制作用。

Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.

作者信息

Kitamura H, Tsuboi M

机构信息

Department of Immunology, Center for Adult Diseases, Osaka, Japan.

出版信息

Immunology. 1989 Feb;66(2):264-9.

PMID:2925225
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1385098/
Abstract

A serum factor, which inhibits haemolysis of the buffer control used in a C3 haemolytic assay, was found in a C3-deficient subject (C3D). Since the buffer control consisted of EAC142, C5 and C6-9 reagent (C6-9R, prepared by treatment of guinea-pig serum with KSCN and hydrazine hydrate), the factor seems to be an inhibitor of C3-independent immune haemolysis. Gel filtration and CM cellulose column chromatography of C3D serum suggested that the inhibitor may be C8. The inhibition was not observed in C8-depleted C3D serum. Furthermore, isolated C8 was found to inhibit haemolysis of EAC142 by C5 and C6-9R in a dose-dependent fashion. Thus, C8 was found to be an inhibitor of C3-independent immune haemolysis in the assay. Further studies revealed that C8 also inhibits haemolysis of EAC142 by C3, C5 and C6-9R (C3 assay system) or that of EAC1423 by C5 and C6-9R (C5 assay system), indicating that C3 or C5 haemolytic activity can be underestimated by the presence of C8 in a sample. C8 did not inhibit haemolysis in the assay system when isolated C6-C9 of human origin were used, but did inhibit haemolysis when isolated C6-C9 of guinea-pig origin was used instead of C6-9R. Thus, it was suggested that the incompatibility of human C8 with guinea-pig C6-C9 might be responsible for this phenomenon. Additional experiments for the mechanism clearly showed that human C8 inhibits the haemolysis of EAC1-7 (EA bearing human C1-C5 and guinea-pig C6 and C7) by guinea-pig C8 and C9 by binding to EAC1-7 prior to guinea-pig C8.

摘要

在一名C3缺陷患者(C3D)中发现了一种血清因子,该因子可抑制C3溶血试验中所用缓冲液对照的溶血现象。由于缓冲液对照由EAC142、C5和C6 - 9试剂(C6 - 9R,通过用硫氰酸钾和水合肼处理豚鼠血清制备)组成,该因子似乎是一种不依赖C3的免疫溶血抑制剂。对C3D血清进行凝胶过滤和CM纤维素柱层析表明,该抑制剂可能是C8。在C8缺失的C3D血清中未观察到这种抑制作用。此外,发现分离出的C8以剂量依赖方式抑制C5和C6 - 9R对EAC142的溶血作用。因此,在该试验中发现C8是一种不依赖C3的免疫溶血抑制剂。进一步研究表明,C8还抑制C3、C5和C6 - 9R对EAC142的溶血作用(C3试验系统)或C5和C6 - 9R对EAC1423的溶血作用(C5试验系统),这表明样品中C8的存在可能会低估C3或C5的溶血活性。当使用人源的分离C6 - C9时,C8在试验系统中不抑制溶血,但当使用豚鼠源的分离C6 - C9代替C6 - 9R时,C8会抑制溶血。因此,提示人C8与豚鼠C6 - C9的不相容性可能是造成这种现象的原因。关于该机制的进一步实验清楚地表明,人C8通过在豚鼠C8之前与EAC1 - 7结合,抑制豚鼠C8和C9对EAC(带有人类C1 - C5以及豚鼠C6和C7的EA)的溶血作用。

相似文献

1
Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.在C3缺陷患者血清中发现的一种血清因子对免疫性溶血的抑制作用。
Immunology. 1989 Feb;66(2):264-9.
2
C3-independent immune haemolysis: mechanism of membrane attack complex formation.不依赖补体C3的免疫性溶血:膜攻击复合物的形成机制
Immunology. 1986 Sep;59(1):147-51.
3
Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.人补体B因子与眼镜蛇毒因子(CVF)的胰蛋白酶激活复合物,可裂解C3和C5,并产生针对未致敏豚鼠红细胞的溶血因子。I. 激活复合物的产生。
Biken J. 1975 Dec;18(4):193-204.
4
Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.补体系统第五和第六成分的激活:C5b6与C(56)a在细胞结合的C3b或A2C介导的溶解增强方面的相似性以及靶细胞的物种偏好
J Immunol. 1981 Sep;127(3):999-1002.
5
The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.补体系统经典途径在液相且无C3时C5的激活。
Immunology. 1986 Jul;58(3):459-65.
6
C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.不依赖C3的免疫溶血:在无C3参与的情况下,C5 - C9对EAC14oxy2细胞的溶血作用
Immunology. 1984 Nov;53(3):575-82.
7
Cyanate as an inactivator of complement proteins.氰酸盐作为补体蛋白的一种灭活剂。
J Immunol. 1975 Dec;115(6):1558-65.
8
Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.C5 - 9复合物对绵羊以外物种红细胞的溶解活性:溶解活性中依赖C9而非C8的变化。
J Immunol. 1977 Oct;119(4):1482-5.
9
Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.人红细胞的补体溶解。两种阵发性夜间血红蛋白尿细胞对C5b-9的不同敏感性。
J Clin Invest. 1979 Aug;64(2):428-33. doi: 10.1172/JCI109479.
10
Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.负责补体介导的细胞溶解的同源物种限制的膜因子:在C8和C9阶段起作用的除衰变加速因子(DAF)之外的一种因子的证据。
J Immunol. 1986 Mar 1;136(5):1777-82.

引用本文的文献

1
Synthesis of the third component of complement (C3) by human gastric cancer-derived cell lines.人胃癌衍生细胞系对补体第三成分(C3)的合成
Clin Exp Immunol. 1993 Nov;94(2):273-8. doi: 10.1111/j.1365-2249.1993.tb03443.x.

本文引用的文献

1
Differences in cell-bound C8 sites on chicken erythrocytes measured by their reactivity with guinea pig and human C9.通过鸡红细胞与豚鼠和人C9的反应性来测定其细胞结合C8位点的差异。
J Immunol. 1980 Dec;125(6):2818-22.
2
Hereditary deficiency of the third component of complement in two sisters with systemic lupus erythematosus-like symptoms.两名患有系统性红斑狼疮样症状的姐妹存在遗传性补体第三成分缺陷。
Arthritis Rheum. 1981 Oct;24(10):1255-60. doi: 10.1002/art.1780241005.
3
Further studies on C9 deficiency.关于C9缺陷的进一步研究。
J Clin Lab Immunol. 1981 Jul;6(1):7-11.
4
Study on C3-like factor in the serum of a C3-deficient subject.C3缺陷患者血清中C3样因子的研究。
Immunology. 1984 Feb;51(2):239-45.
5
C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.不依赖C3的免疫溶血:在无C3参与的情况下,C5 - C9对EAC14oxy2细胞的溶血作用
Immunology. 1984 Nov;53(3):575-82.
6
The reaction mechanism of human C5 in immune hemolysis.人补体C5在免疫溶血中的反应机制。
J Exp Med. 1970 Oct 1;132(4):775-93. doi: 10.1084/jem.132.4.775.
7
An analogue of guinea pig C8: in vitro generation and inhibitory activity.豚鼠补体C8类似物:体外生成及抑制活性
J Immunol. 1970 May;104(5):1212-9.
8
The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency.人类补体的第八成分(C8):分离、特性鉴定及溶血效率
J Exp Med. 1969 Nov 1;130(5):1145-60. doi: 10.1084/jem.130.5.1145.
9
Studies on the C'3d of guinea pig complement.豚鼠补体C'3d的研究
Biken J. 1967 Sep;10(3):143-53.
10
Molecular analysis of the reaction of C9 with EAC1-8: reaction of C9 with EAC1-8.C9与EAC1 - 8反应的分子分析:C9与EAC1 - 8的反应
J Immunol. 1974 Dec;113(6):1992-2003.